Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.  

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

The new site will have up to eight times the manufacturing capacity of any other radiopharmaceutical facility.